Antimicrobial Susceptibility Testing Market Size, Share, Trends, Growth and Forecast 2032

Antimicrobial Susceptibility Testing Market Insights

According to the report published by Zion Market Research, the global Antimicrobial Susceptibility Testing Market size was valued at USD 3.75 Billion in 2023 and is predicted to reach USD 5.91 Billion by the end of 2032. The market is expected to grow with a CAGR of 5.2% during the forecast period. The report analyzes the global Antimicrobial Susceptibility Testing Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Antimicrobial Susceptibility Testing industry.

Request Free Sample

Global Antimicrobial Susceptibility Testing Market: Overview

Antimicrobial susceptibility testing (AST) is a laboratory testing procedure performed by clinical laboratory scientists to determine which antimicrobial treatment is ideal for individual cases of infectious diseases. A majority of infectious diseases, it is found, are bacterial in origin. Although bacterial infections rarely prove to be deadly, they can significantly affect an individual’s quality of life.

Clinical laboratories presently use numerous antimicrobial susceptibility testing methods that include minimum inhibitory concentration (MIC) and disk diffusion methods. Adopting both genotypic and phenotypic identification of bacterial resistance, commercial methods of antimicrobial susceptibility testing also made a debut across hospitals and health centers.

Global Antimicrobial Susceptibility Testing Market: Growth Factors

With the outbreak of the Covid-19 pandemic, hospitals, clinics, and health centers began concentrating on SARS-CoV-2 testing for identifying patients affected by the novel coronavirus. Even though the hiatus of global demand for AST resulted in major losses, the global antimicrobial susceptibility testing market will be back on track by 2021. The massive upsurge in the frequency of infectious diseases is one of the crucial important factors driving the growth of the antimicrobial susceptibility testing market. Salmonella, Escherichia coli (E coli), bacterial pneumonia, clostridium difficile (C. diff), tuberculosis, and heliobacter pylorim (H. pylori) are some most common bacterial infections affecting millions each year.

As the percentage of population diagnosed with immunodeficiency disorders such as diabetes, HIV/AIDS, and cancer escalates, the frequency of bacterial infections will also increase, boosting the demand for antimicrobial susceptibility testing products. The high prevalence of chronic diseases, coupled with lower immunity levels amongst the population, is likely to reinforce the demand for antimicrobial susceptibility testing kits and products over the forecast period.

High costs of latest antimicrobial susceptibility testing methods, along with stringent approval regulations might curb the growth of the market over the forthcoming times. However, the broadening healthcare budgets of several governments across the globe are likely to support the expansion of the market, ensuring consistent progress. 

Request Free Sample

Global Antimicrobial Susceptibility Testing Market: Segmentation

The global antimicrobial susceptibility testing market can be segmented on the basis of type of product, type of testing, method, end-user, application, and region. Automated laboratory instruments, MIC strips, susceptibility testing disks, susceptibility testing plates, and consumables are some key segments by product type.

According to testing type, the market can be divided into anti-fungal, anti-bacterial, and anti-parasitic testing. In the forthcoming period, the anti-bacterial testing segment is likely to register remarkable growth due to drug resistance among patients. Etest method, disk diffusion, and genotyping methods are the prominent segments by testing method. Based on end-user, the global antimicrobial susceptibility testing market can be classified into pharmaceutical companies, diagnostic centers & hospitals, clinical research organizations, and academic institutes. Drug development & drug discovery, clinical diagnostics, epidemiology, environmental monitoring, and bioterrorism surveillance are some major segments when categorized on the basis of application.

Antimicrobial Susceptibility Testing Market: Report Scope

Global Antimicrobial Susceptibility Testing Market: Regional Analysis

North America claimed the largest share of the global antimicrobial susceptibility testing market in the past and is expected to grow at a promising CAGR over the projected timeline, thanks to the major market players such as Thermo Fisher and Becton, Dickinson, and Company being located in the region. The high prevalence of bacterial diseases, increasing healthcare expenditures, and favorable government initiatives are responsible for the growth of North America antimicrobial susceptibility testing market.

Asia Pacific will rise to prominence over the coming times, galvanized by rising awareness about technologically advanced antimicrobial susceptibility testing methods, growing concerns about the spread of infectious diseases, high density of population resulting in pollution and high degree of contagion. Moreover, the healthcare infrastructure in emerging economies such as India has been witnessing an upgradation, thanks to increasing government spending on healthcare facilities. As a result, driven by these factors, the Asia Pacific antimicrobial susceptibility testing market will present abundant growth opportunities in the coming times.

Global Antimicrobial Susceptibility Testing Market: Competitive Players

The global antimicrobial susceptibility testing market is extremely fragmented, considering the presence of innumerable market players including :

• Thermo Fisher Scientific
• Roche Diagnosis Limited
• bioMerieux SA
• Merck KGaA
• Danaher Corporation
• ELITech Group
• InvivoGen
• Accelerate Diagnostics, Inc.
• Alifax S.r.l.
• Becton,
• Dickinson
• Company, Biotron Ltd.
• Creative Diagnostics.

Investment in R&D activities is the primary business tactic adopted by several antimicrobial susceptibility testing manufacturers.

The Global Antimicrobial Susceptibility Testing Market is segmented as follows:
    
By Type of product 

• Automated laboratory instruments
• MIC strips
• susceptibility testing disks 
• susceptibility testing plates
• consumables

By Type of testing 

• anti-fungal 
• anti-bacterial
• anti-parasitic testing

By method 

• Etest method
• disk diffusion 
• genotyping methods

By End-user 

• pharmaceutical companies
• diagnostic centers & hospitals 
• clinical research organizations
• academic institutes

By Application 

• Drug development & drug discovery
• clinical diagnostics
• epidemiology
• environmental monitoring
• bioterrorism surveillance

Global Antimicrobial Susceptibility Testing Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.